King Faisal Specialist Hospital & Research Centre (KFSH) has reported a five-year survival rate of 95.2% among children treated for Wilms tumor, the most common form of kidney cancer in children, based on an analysis of 104 children diagnosed and treated at KFSH with long-term follow-up.

 

The medical team determines each child’s treatment plan based on the tumor stage, test results, overall health, and, when needed, specific tumor characteristics. Treatment for Wilms tumor typically involves surgery and chemotherapy, with radiation therapy used in selected cases. Surgery may involve removing all or part of the affected kidney, while chemotherapy may be given before or after surgery depending on the child’s condition and tumor characteristics.

 

Wilms tumor develops in the kidneys during childhood and may initially progress without obvious symptoms. In some cases, it is discovered after a lump or swelling is noticed in the child’s abdomen. Other possible signs include abdominal pain, blood in the urine, high blood pressure, fever, loss of appetite and weight loss.

 

Dr. Awatif Alanazi, Consultant Pediatric Hematology and Oncology at King Faisal Specialist Hospital & Research Centre, explained that treating Wilms tumor requires consideration not only of the tumor itself, but also of the child’s kidney health. As the disease occurs early in life, preserving kidney function remains an important consideration throughout the course of treatment.

 

KFSH’s long-term follow-up of Wilms tumor cases has produced a substantial body of clinical data. The findings support the ongoing evaluation of treatment practices and outcomes and help guide improvements in care for children with the disease.

 

King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and Africa and 12th globally among the world’s top 250 academic medical centers for 2026. It was also recognized as the most valuable healthcare brand in the Kingdom and the Middle East for 2026, according to Brand Finance, and listed by Newsweek among the World’s Best Hospitals, World’s Best Smart Hospitals, and World’s Best Specialized Hospitals for 2026.